MarginsXMarginsX
Home › Markets › Health Care › CDNA

CareDx Inc. (CDNA)

CDNA trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$73.72
-5.34% on the day
Market cap
$3.9B
Mid cap
Revenue · 2025
$379.8M
+13.8% on 2024
Net income · 2025
-$21.4M
-5.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1217234/000121723426000018/0001217234-26-000018-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCDNA on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2014
SEC CIK0001217234
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$379.8M
Net income-$21.4M
Operating income-$30.8M
Net margin-5.6%
Operating margin-8.1%
Revenue growth+13.8%
Cash$65.4M
Total assets$413.2M
P/E (computed)Net income was not positive
P/S (computed)10.2×

Warning signs

Cash runway
Cash-flow positive
$250.5M cash at September 30, 2026
Share count, 1 year
+2.2%
2025-10-30 to 2026-10-26 · -2.9% over 3 years
Going-concern doubt
No
10-Q filed October 29, 2026
Insider net buying, 12 months
-$13.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-29
Cash and burn$250.5M cash; operating cash flow $17.3M a quarter.Report 2026-09-30
Shares outstanding52,542,786 (2026-10-26); 51,432,639 a year earlier; 54,098,378 three years earlier.Cover page 2026-10-26
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-04-28
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, San Francisco, California, United StatesPCAOB Form AP 2026-03-17
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $13.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$139.4M$19.3M$12.7M$250.5MNo debt tags$497.4M10-Q 2026-10-29
Q2 2026
2026-06-30
$131.9M$110.6M$30.6M$373.6MNo debt tags$458.1M10-Q 2026-07-30
Q1 2026
2026-03-31
$117.7M$2.8M$4.3M$77.9MNo debt tags$412.8M10-Q 2026-04-28
Q4 2025
2025-12-31
$108.4M-$4.1M$21.4M$65.4MNo debt tags$379.8M10-K 2026-02-25
Q3 2025
2025-09-30
$100.1M$1.7M$37.4M$91.4MNo debt tags$358.0M10-Q 2026-10-29
Q2 2025
2025-06-30
$86.7M-$8.6M$9.9M$68.2MNo debt tags$340.8M10-Q 2026-07-30
Q1 2025
2025-03-31
$84.7M-$10.4M-$26.6M$88.7MNo debt tags$346.4M10-Q 2026-04-28
Q4 2024
2024-12-31
$86.6M$87.7M$21.9M$114.7MNo debt tags$333.8M10-K 2026-02-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-04-28
Latest annual report10-K2026-02-25
Latest quarterly / interim10-Q2026-10-29
Latest current report8-K2026-10-29
Latest proxyDEFA14A2026-06-05

Source: SEC EDGAR submissions feed, 1,005 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-0.9%
1 month+19.0%
3 months+64.4%
Year to date+313.4%
1 year+390.7%
From 52-week high-12.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
ACHCAcadia Healthcare Company Inc.$38.70+2.44%$3.6B
BLLNBillionToOne Inc.$96.31-8.41%$4.6B
GRALGRAIL Inc. Common Stock$105.60-8.88%$4.7B
CELCCelcuity Inc.$60.57-5.90%$3.0B
CONConcentra Group Holdings Parent Inc.$43.44+2.09%$5.5B
CLOVClover Health Investments Corp.$4.95-0.20%$2.7B
CAICaris Life Sciences Inc.$21.00-8.85%$6.0B
RDNTRadNet Inc.$76.89+0.61%$6.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier